United States of America, ex rel. Charles R. Shepherd and Danny V. Rude; Robert Scott Dillard; and Rickey Mackey v. Fluor Corporation, Inc., Fluor Intercontinental, Inc.

District Court, D. South Carolina·Decided January 14, 2026·No. 6:13-cv-02428·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA GREENVILLE DIVISION

UNITED STATES OF AMERICA, ex ) CASE NO.: 6:13-cv-02428-JD rel. CHARLES R. SHEPHERD and ) DANNY V. RUDE; ROBERT SCOTT ) DILLARD; and RICKEY MACKEY, ) ) Plaintiff-Relators, ) Memorandum Opinion and Order ) on Defendants’ Motion to v. ) Exclude Rudolph ) FLUOR CORPORATION, INC.,) FLUOR INTERCONTINENTAL, INC., ) ) Defendants. ) )

Before the Court is Defendants Fluor Corporation, Inc., and Fluor Intercontinental, Inc.’s Motion to Exclude the Testimony of Relators’ Expert Michael Rudolph pursuant to Federal Rules of Evidence 702 and 403 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). (DE 544.) Relators have filed a Response in Opposition (DE 565), supported by the expert reports of Michael Rudolph and Brigadier General (Ret.) Mike Hoskin (DE 575; DE 576), and Fluor has filed a Reply (DE 583). The motion challenges the admissibility and scope of Mr. Rudolph’s proposed expert testimony concerning inventory management, property accountability, and related issues arising from Fluor’s performance under the LOGCAP IV contract and Task Order 0005 in Afghanistan. Specifically, Fluor contends that Mr. Rudolph is not qualified to offer several of his proffered opinions, his methodology is unreliable, and portions of his testimony are irrelevant, impermissibly speculative, or unfairly prejudicial. For the reasons below, the Court grants the motion (DE 544) in part and denies

it in part. I. BACKGROUND1 A. Factual Background This action arises under the False Claims Act and concerns Defendants Fluor Corporation, Inc., and Fluor Intercontinental, Inc.’s (“Fluor”) performance of logistics and life-support services for the United States military in Afghanistan under the Logistics Civil Augmentation Program IV (“LOGCAP IV”) contract and Task Order

0005 (“TO5”). Relators allege, among other things, that Fluor knowingly submitted false claims and false statements to the Government in connection with award-fee determinations and property-management obligations, and that Fluor retaliated against employees who raised concerns regarding those practices. (See generally Am. Compl. 2d, DE 121.) Under LOGCAP IV, Fluor was awarded an indefinite-delivery, indefinite-

quantity contract to provide life-support and logistics services to U.S. military operations overseas. (LOGCAP IV Contract, DE 507-2.) Fluor performed under

1 For ease of reference, the Court uses the following acronyms throughout this Order: “LOGCAP IV” refers to the Logistics Civil Augmentation Program IV contract; “TO5” refers to Task Order 5 issued under LOGCAP IV; “FAR” refers to the Federal Acquisition Regulation; “DFARS” refers to the Defense Federal Acquisition Regulation Supplement; “DCMA” refers to the Defense Contract Management Agency; “PMS” refers to a contractor’s Property Management System; “PMSA” refers to a Property Management System Analysis conducted by DCMA; and “LTDD” refers to Loss, Theft, Damage, and Destruction reports submitted by a contractor concerning Government property. discrete task orders that defined the scope of work at particular locations. (Id.) In 2009, Fluor was awarded TO5, which required Fluor to provide base life-support services at forward operating bases throughout Northern Afghanistan. (TO5, DE 507-

4; Performance Work Statement.) TO5 was structured as a cost-plus-award-fee contract. Under that structure, Fluor could recover allowable costs and earn a base fee for minimal performance, as well as an additional award fee determined by the Government based on periodic evaluations of Fluor’s performance. (LOGCAP IV § H-35, DE 507-2 at 36–38.) Among the areas evaluated were Fluor’s compliance with property-management

requirements and its effectiveness in managing Government-furnished and contractor-acquired property. (See, e.g., Property Management System Analysis (“PMSA”) materials discussed in DE 565 at 10-11.) In support of their claims, Relators designated Michael Rudolph as an expert witness. Mr. Rudolph is a retired Marine Corps officer with decades of experience in logistics, supply chain management, and inventory control, including service in combat and contingency environments. (Rudolph Rep. at 5–6, DE 575.) According to

his report, Mr. Rudolph reviewed Fluor’s inventory management practices, property management systems, audit findings, and related records, and offers opinions regarding the adequacy of those practices and the operational significance of recurring deficiencies identified during Fluor’s performance of TO5. (DE 575-1 at 47– 50, DE 575-2 at 1–17.) B. The Parties’ Positions Fluor moves to exclude Mr. Rudolph’s testimony in whole or in part pursuant to Federal Rules of Evidence 702 and 403. (DE 544.) Fluor contends that Mr. Rudolph

lacks the qualifications to opine on contractual and regulatory requirements, Government decision-making, and alleged consequences, such as award-fee determinations, loss of relief of responsibility, or suspension and debarment. (DE 544- 1 at 7–8.) Fluor further argues that Mr. Rudolph employs no reliable methodology to support several of his opinions and that portions of his proposed testimony consist of impermissible legal conclusions, speculation regarding intent or state of mind, or

narrative argument rather than expert analysis. (Id. at 21–30.) Relators oppose the motion, asserting that Mr. Rudolph’s extensive experience in military logistics and inventory management qualifies him to offer the challenged opinions, that his testimony is grounded in a reliable review of the record and accepted logistics principles, and that his opinions will assist the jury in understanding operational issues relevant to Fluor’s performance and representations to the Government. (DE 565.)

Fluor replies that Relators recast Mr. Rudolph’s opinions and argues that the proffer remains inadmissible because the opinions are irrelevant or outside his expertise, unsupported by reliable methodology, or unfairly prejudicial. (DE 583.) II. LEGAL STANDARD District courts “must ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable.” Daubert v. Merrell Dow Pharm. Inc., 509 U.S. 579, 589 (1993). Rule 702 of the Federal Rules of Evidence was amended in response to Daubert and its progeny to provide: A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if the proponent demonstrates to the court that it is more likely than not that: (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert’s opinion reflects a reliable application of the principles and methods to the facts of the case. Fed. R. Evid. 702. The proponent of an expert witness’s testimony bears the burden of proving that such testimony meets the requirements of Rule 702 by a preponderance of evidence. See Cooper v.

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America, ex rel. Charles R. Shepherd and Danny V. Rude; Robert Scott Dillard; and Rickey Mackey v. Fluor Corporation, Inc., Fluor Intercontinental, Inc., (D.S.C. 2026).

United States of America, ex rel. Charles R. Shepherd and Danny V. Rude; Robert Scott Dillard; and Rickey Mackey v. Fluor Corporation, Inc., Fluor Intercontinental, Inc. (United States of America, ex rel. Charles R. Shepherd and Danny V. Rude; Robert Scott Dillard; and Rickey Mackey v. Fluor Corporation, Inc., Fluor Intercontinental, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
General Electric Co. v. Joiner
522 U.S. 136 (Supreme Court, 1997)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Santos v. Posadas De Puerto Rico Associates, Inc.
452 F.3d 59 (First Circuit, 2006)
United States v. Charles Alton Sellers, Jr.
566 F.2d 884 (Fourth Circuit, 1977)
Cooper v. Smith & Nephew, Inc.
259 F.3d 194 (Fourth Circuit, 2001)
Howard Nease v. Ford Motor Company
848 F.3d 219 (Fourth Circuit, 2017)
Lipitor (Atorvastatin Calcium) Mktg. v. Pfizer, Inc.
892 F.3d 624 (Fourth Circuit, 2018)
United States v. Michael Smith
919 F.3d 825 (Fourth Circuit, 2019)
Andrea Sardis v. Overhead Door Corporation
10 F. 4th 268 (Fourth Circuit, 2021)
Bruno v. Bozzuto's, Inc.
311 F.R.D. 124 (M.D. Pennsylvania, 2015)